login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
OLEMA PHARMACEUTICALS INC (OLMA) Stock News
USA
- NASDAQ:OLMA -
US68062P1066
-
Common Stock
20.6701
USD
-1.34 (-6.09%)
Last: 11/21/2025, 10:17:06 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
OLMA Latest News, Press Relases and Analysis
All
Press Releases
22 hours ago - By: Chartmill
- Mentions:
VRA
ANVS
RPTX
INM
...
In today's session, these stocks are experiencing unusual volume.
a day ago - By: Chartmill
- Mentions:
PBM
HUSA
TXMD
CMCT
...
Keep an eye on the top gainers and losers in Thursday's session.
19 hours ago - By: Olema Oncology
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
19 hours ago - By: Olema Oncology
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
a day ago - By: Benzinga
- Mentions:
GRI
PBM
SCLX
PACS
...
12 Health Care Stocks Moving In Thursday's Intraday Session
a day ago - By: The Motley Fool
- Mentions:
HTFL
VZ
NAMS
CDTX
...
Investment Powerhouse Backs Biotech Stock to the Tune of $419 Million
a day ago - By: Benzinga
- Mentions:
EXAS
WMT
NFE
PACS
...
Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday
a day ago - By: The Motley Fool
- Mentions:
CDTX
HTFL
NAMS
PHVS
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer
2 days ago - By: Chartmill
- Mentions:
IDN
STEC
VRA
CANF
...
In today's session, these stocks are experiencing unusual volume.
2 days ago - By: Olema Oncology
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock
2 days ago - By: Olema Oncology
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock
3 days ago - By: Olema Oncology
Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
3 days ago - By: Olema Oncology
Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
3 days ago - By: Chartmill
- Mentions:
VNDA
ZYXI
ONDS
CPOP
...
Which stocks are moving on Tuesday?
3 days ago - By: Chartmill
- Mentions:
PLUG
NVDA
OPEN
CANF
...
Which stocks are most active on Tuesday?
3 days ago - By: Chartmill
- Mentions:
VNDA
CMCT
ARVN
ZYXI
...
Top movers in Tuesday's session
3 days ago - By: Chartmill
- Mentions:
VNDA
ENR
UUU
GSM
...
Let's uncover which stocks are experiencing notable gaps during today's session.
3 days ago - By: Stocktwits
- Mentions:
VFMO
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results
3 days ago - By: Investor's Business Daily
- Mentions:
LLY
Why Roche's Positive Test Results Sent Olema Pharma Skyrocketing 200%
11 days ago - By: Olema Oncology
Olema Oncology Reports Third Quarter 2025 Financial and Operating Results
11 days ago - By: Olema Oncology
Olema Oncology Reports Third Quarter 2025 Financial and Operating Results
17 days ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 days ago - By: Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 days ago - By: Olema Oncology
Olema Oncology to Participate in Upcoming Investor Conferences
18 days ago - By: Olema Oncology
Olema Oncology to Participate in Upcoming Investor Conferences
22 days ago - By: Olema Oncology
Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib at SABCS 2025
22 days ago - By: Olema Oncology
Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib at SABCS 2025
Please enable JavaScript to continue using this application.